Thursday, February 28, 2013

• 2012 Stem Cell Standouts And The Outlook For 2013at Seeking Alpha (Thu, Feb 28)

Wednesday, February 27, 2013

• New Orphan Drug Designation For Pluristem Could Gain Access To FDA 'Progressive Approval'at Seeking Alpha (Wed, Feb 27)

Tuesday, February 26, 2013

• Pluristem Therapeutics moves toward Phase I study of PLX-PAD Cells for PAHat theflyonthewall.com (Tue, Feb 26)
• United Therapeutics Moves Forward Towards a Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial HypertensionGlobeNewswire (Tue, Feb 26)

Monday, February 25, 2013

• Pluristem Therapeutics, Inc. Announces Its Sr. VP of Corporate Development Will Be Presenting at the Accredited Members Spring Micro Cap Investor Conference in Las VegasMarketwired (Mon, Feb 25)

Thursday, February 21, 2013

• Pluristem Gets FDA's Orphan Drug Nod for Anemia Treatmentat Motley Fool (Thu, Feb 21)
• PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Other EventsEDGAR Online (Thu, Feb 21)
• 4 Biotech Stocks Under $10 Moving Higherat TheStreet (Thu, Feb 21)
• Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplastic AnemiaGlobeNewswire (Thu, Feb 21)

Friday, February 15, 2013

• U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year PreviousMarketwired (Fri, Feb 15)

Thursday, January 31, 2013

• PLURISTEM THERAPEUTICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Jan 31)
• Pluristem Moves to New FacilityZacks (Thu, Jan 31)

Tuesday, January 22, 2013

• 3 Regenerative Medicine Companies That Could Deliver In 2013at Seeking Alpha (Tue, Jan 22)
• Athersys: Short Term Catalyst With Long Term PotentialMarketwired (Tue, Jan 22)

Friday, January 18, 2013

• Rumors, News and Biotech Buzz Present Various Trade OpportunitiesMarketwired (Fri, Jan 18)

Wednesday, January 16, 2013

• Why Pluristem Therapeutics Is Poised to Plungeat Motley Fool (Wed, Jan 16)
• Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013Marketwired (Wed, Jan 16)

Tuesday, January 15, 2013

• PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Other EventsEDGAR Online (Tue, Jan 15)

Monday, January 7, 2013

• PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 7)

Friday, January 4, 2013

• Pluristem Progresses with New FacilityZacks (Fri, Jan 4)

Wednesday, January 2, 2013

• Stem Cells, Dr. Oz And A Potentially Lucrative Investment Opportunityat Seeking Alpha (Wed, Jan 2)

Saturday, December 29, 2012

• 3 Horrendous Health-Care Stocks This Weekat Motley Fool (Sat, Dec 29)

Wednesday, December 26, 2012

• PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and EEDGAR Online (Wed, Dec 26)

Thursday, December 20, 2012

• The Rosen Law Firm Announces Investigation of Securities Claims Against Pluristem Therapeutics, Inc. --- PSTIBusiness Wire (Thu, Dec 20)

Friday, December 14, 2012

• Has Geron Become the Perfect Stock?at Motley Fool (Fri, Dec 14)

Add PSTI News to My Yahoo!